Related Experiment Videos
Novel targets and new potential: developments in the treatment of inflammation in chronic kidney disease
Csaba P Kovesdy1, Kamyar Kalantar-Zadeh
1Salem VAMC (111D), 1970 Roanoke Blvd., Salem, VA 24153, USA. csaba.kovesdy@va.gov
Insights
Chronic inflammation significantly increases mortality in chronic kidney disease (CKD). While no approved anti-inflammatory drugs exist for CKD, research into new therapies is ongoing to improve patient outcomes.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Immunology
Background:
- Chronic kidney disease (CKD) is associated with high mortality, primarily from cardiovascular causes.
- Traditional risk factors do not fully explain the elevated cardiovascular mortality in CKD patients.
- Chronic inflammation is an emerging risk factor contributing to increased mortality in CKD.
Purpose of the Study:
- To elucidate the role of inflammation in the pathophysiology of CKD.
- To review current and potential anti-inflammatory pharmacologic therapies for CKD.
Main Methods:
- Comprehensive literature review.
- Incorporation of expert opinion.
Main Results:
- Inflammation is a prevalent and critical issue in patients with CKD.
- Currently, no specific anti-inflammatory pharmacologic therapies are approved for CKD treatment.
- Several anti-inflammatory agents are under investigation in early-phase clinical trials.
Conclusions:
- Inflammation plays a significant role in CKD progression and outcomes.
- Future therapeutic strategies may involve targeting chronic inflammation in CKD.
- Emerging anti-inflammatory agents show promise for future CKD management.
Background:
Patients with chronic kidney disease (CKD) of all stages experience extremely high mortality, with cardiovascular causes accounting for about half of all their deaths. Traditional risk factors such as hypertension, hypercholesterolemia and diabetes mellitus cannot explain the excessively high cardiovascular mortality in CKD. Chronic inflammation is one of the novel risk factors that appear to contribute to the increased mortality seen in patients with CKD. Therapeutic interventions targeting chronic inflammation in CKD may lead to improved outcomes.
Objectives:
To describe the role of inflammation in CKD and to review anti-inflammatory pharmacologic therapies that could have a role in its therapy.
Methods:
A review of the literature was carried out and expert opinion expressed.
Results/Conclusion:
Inflammation is a common and significant problem in CKD. There are currently no approved pharmacologic anti-inflammatory therapies in CKD but several agents are being studied in early clinical trials, while others could become viable alternatives in the future.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Chronic Inflammation: Introduction